Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents

Details for Australian Patent Application No. 2002325860 (hide)

Owner Pharmacia Italia S.p.A.

Inventors Salom, Barbara; Varasi, Mario; Nesi, Marcella; Amici, Raffaella; Villa, Manuela; Pevarello, Paolo; Traquandi, Gabriella; Vulpetti, Anna; Brasca, Maria Gabriella

Agent Griffith Hack

Pub. Number AU-B-2002325860

PCT Number PCT/EP02/07289

PCT Pub. Number WO2003/008365

Priority 60/357,642 20.02.02 US; 09/907,947 19.07.01 US

Filing date 2 July 2002

Wipo publication date 3 March 2003

Acceptance publication date 13 March 2008

International Classifications

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/357,642 20.02.02 US; 09/907,947 19.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002325860

13 March 2008 Application Accepted

  Published as AU-B-2002325860

10 July 2008 Standard Patent Sealed

4 September 2008 Assignment Registered

  Pharmacia Italia S.p.A The patent has been assigned to Pfizer Italia S.r.l.

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325861-SEMICONDUCTOR STRUCTURE COMPRISING A MAGNETORESISTOR

2002325859-Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms